Tag Archive for: MDR bacteria; AMR

Collaboration

LimmaTech Biologics acquires licence option for AbVacc vaccine LBT-SA7

Swiss LimmaTech Biologics and AbVacc Inc have agreed to co-develop AbVacc’s preclinical Staphylococcus aureus vaccine LBT-SA7 (formerly IBT-V02) in case of Phase I success.

Read more